Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cryoprecipitate therapy in amniotic fluid embolization.

G P Rodgers, G J Heymach

    The American Journal of Medicine
    |May 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Olfactomedin 4 deletion induces colon adenocarcinoma in Apc<sup>Min/+</sup> mice.

    Oncogene·2016
    Same author

    Expression of hGC-1 is correlated with differentiation of gastric carcinoma.

    Histopathology·2007
    Same author

    Polymorphisms within the angiotensinogen gene (GT-repeat) and the risk of stroke in pediatric patients with sickle cell disease: a case-control study.

    American journal of hematology·2002
    Same author

    ACC/AHA clinical competence statement on electrocardiography and ambulatory electrocardiography: A report of the ACC/AHA/ACP-ASIM task force on clinical competence (ACC/AHA Committee to develop a clinical competence statement on electrocardiography and ambulatory electrocardiography) endorsed by the International Society for Holter and noninvasive electrocardiology.

    Circulation·2001
    Same author

    ACC/AHA clinical competence statement on electrocardiography and ambulatory electrocardiography. A report of the ACC/AHA/ACP-ASIM Task Force on Clinical Competence (ACC/AHA Committee to Develop a Clinical Competence Statement on Electrocardiography and Ambulatory Electrocardiography).

    Journal of the American College of Cardiology·2001
    Same author

    Nitric oxide transport on sickle cell hemoglobin: where does it bind?

    Free radical research·2001
    Same journal

    Mineralocorticoid Antagonists for Post-MI HFpEF: Plausible Biology Meets Low Residual Risk?

    The American journal of medicine·2026
    Same journal

    GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

    The American journal of medicine·2026
    Same journal

    Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

    The American journal of medicine·2026
    Same journal

    Cave Canem - Beware of the Dog.

    The American journal of medicine·2026
    Same journal

    Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

    The American journal of medicine·2026
    Same journal

    Mesenteric panniculitis.

    The American journal of medicine·2026
    See all related articles

    Cryoprecipitate improved a patient with severe adult respiratory distress syndrome due to amniotic fluid embolus. Fibronectin, not fibrinogen, may be key for recovery in these critical obstetric emergencies.

    Area of Science:

    • Obstetrics and Gynecology
    • Hematology
    • Critical Care Medicine

    Background:

    • Severe adult respiratory distress syndrome (ARDS) is a life-threatening complication.
    • Amniotic fluid embolus (AFE) is a rare but catastrophic obstetric emergency.
    • Cytological diagnosis of AFE allows for targeted management.

    Observation:

    • A patient with cytologically confirmed AFE and severe ARDS received cryoprecipitate.
    • Following cryoprecipitate administration, significant cardiopulmonary and hematologic improvement was observed.
    • The patient experienced a full recovery without long-term complications.

    Findings:

    • Cryoprecipitate administration led to marked clinical improvement in a patient with AFE-induced ARDS.
    • Fibronectin (cold-insoluble globulin), a component of cryoprecipitate, is hypothesized to be the primary therapeutic agent.

    Related Experiment Videos

  • This contrasts with the traditional focus on fibrinogen in managing coagulopathies associated with AFE.

    • Implications:

    • Fibronectin replacement may be a crucial therapeutic strategy for AFE patients with ARDS.
    • Further research is warranted to elucidate the role of fibronectin in AFE and ARDS.
    • This case highlights the potential benefit of cryoprecipitate, likely due to its fibronectin content, in managing severe AFE.